Food and Drug Administration

Praxis Precision Medicine Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

by
Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. FDA has set a PDUFA target date of September 27, 2026 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) — Praxis Precision MedicineInc. (NASDAQ: PRAX), a fully integrated, central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has accepted for priority review its New … Read more

Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

by
Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they can put in their products, a change that could open the way for the marketing of peptides, probiotics and other cutting-edge health offerings. The FDA held a public meeting on Friday to discuss the long-term criteria for … Read more

Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

by
Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they can put in their products, a change that could open the way for the marketing of peptides, probiotics and other cutting-edge health offerings. The FDA held a public meeting on Friday to discuss the long-term criteria for … Read more

Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

by
Dietary supplement makers are pushing the FDA to allow peptides and other new ingredients

Makers of dietary supplements are pushing the Food and Drug Administration to expand the types of ingredients they can put in their products, a change that could open the way for the marketing of peptides, probiotics and other cutting-edge health offerings. The FDA held a public meeting on Friday to discuss the long-term criteria for … Read more